Canadian Patent No. 2,098,738 is set to expire on November 25, 2012. This patent is likely unique in the history of Canadian patented medicines in that its expiry is not being hailed as a benefit to the Canadian public by providing for the entry of lower priced generic. Rather, the expiry of this particular patent is being met with grave concern. The reason is Canadian Patent No. 2,098,738 has...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Implications of OxyContin Patent Expiring in Canada
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account